BioWorld MedTech Patent Highlights: Week 30 From Current Patent Gazette Aug. 6, 2021 BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.Read More
Canada’s Rx price review board slapped for overstepping its bounds Aug. 5, 2021 By Mari Serebrov Canada’s Federal Court of Appeal took the Patented Medicine Prices Review Board to task for ordering Alexion Pharmaceuticals Inc. to “forfeit excess revenues” generated by Soliris (eculizumab) between 2009 and 2017. Read More
The University of Washington and the Department of Veterans Affairs patent glycolysis inhibitors Aug. 5, 2021
RSS